What is the appropriate intravenous dose of 20% mannitol for a 20‑kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mannitol 20% Dosing for a 20 kg Child

For a 20 kg child, administer 5-20 grams of mannitol 20% (25-100 mL) intravenously over 20-30 minutes for increased intracranial pressure, with the typical starting dose being 10 grams (50 mL). 1

Dosing Algorithm

The American Academy of Pediatrics guidelines provide clear weight-based dosing for pediatric patients 1:

  • Standard dose range: 0.25-1 g/kg IV over 20-30 minutes
  • For your 20 kg patient: This translates to 5-20 grams total dose
  • Acute intracranial hypertensive crisis: May use higher doses of 0.5 g/kg over 15 minutes (10 grams for this child)

Practical Calculation for 20% Mannitol

Since 20% mannitol contains 200 mg/mL (0.2 g/mL):

  • Low dose (0.25 g/kg): 5 grams = 25 mL
  • Standard dose (0.5 g/kg): 10 grams = 50 mL
  • High dose (1 g/kg): 20 grams = 100 mL

Administration Details

Infusion rate: Administer over 20-30 minutes for standard dosing 1. In acute herniation scenarios, the 0.5 g/kg dose may be given over 15 minutes 1.

Critical preparation steps:

  • Use a filter when administering 25% concentrations 2
  • Warm crystallized solutions in hot water at 80°C before use 2
  • Place urinary catheter before administration 1
  • Monitor serum osmolality to avoid hyperosmolality 1

Clinical Context

The FDA labeling confirms pediatric dosing of 1-2 g/kg for intracranial pressure reduction 2, though the AAP guidelines provide a broader range starting at 0.25 g/kg 1. Start with lower doses (0.25-0.5 g/kg) and titrate upward based on ICP response, as recent evidence suggests equiosmolar dosing (approximately 250 mOsm) is the key therapeutic target 3.

Important Caveats

  • Concurrent therapies: Mannitol should be part of multimodal ICP management including head-of-bed elevation, sedation/analgesia, and consideration of CSF drainage 1
  • Monitoring: Watch for rebound ICP, electrolyte disturbances, and renal function 2
  • Alternative consideration: Recent pediatric data suggests 3% hypertonic saline may be more effective than mannitol for CNS infections 4, though both agents show similar efficacy in trauma 5

References

Research

Randomized Clinical Trial of 20% Mannitol Versus 3% Hypertonic Saline in Children With Raised Intracranial Pressure Due to Acute CNS Infections.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2020

Research

Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.